Published in PLoS One on February 28, 2013
Traditional Chinese medicine and cancer: History, present situation, and development. Thorac Cancer (2015) 0.86
Anti-tumor enhancement of Fei-Liu-Ping ointment in combination with celecoxib via cyclooxygenase-2-mediated lung metastatic inflammatory microenvironment in Lewis lung carcinoma xenograft mouse model. J Transl Med (2015) 0.86
The role of acupoint stimulation as an adjunct therapy for lung cancer: a systematic review and meta-analysis. BMC Complement Altern Med (2013) 0.85
The effect of electroacupuncture on osteosarcoma tumor growth and metastasis: analysis of different treatment regimens. Evid Based Complement Alternat Med (2013) 0.82
Does the couse of astragalus-containing chinese herbal prescriptions and radiotherapy benefit to non-small-cell lung cancer treatment: a meta-analysis of randomized trials. Evid Based Complement Alternat Med (2013) 0.81
Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer. Sci Rep (2016) 0.80
Distributions of usage and the costs of conventional medicine and traditional chinese medicine for lung cancer patients in taiwan. Evid Based Complement Alternat Med (2013) 0.80
A survey of chinese medicinal herbal treatment for chemotherapy-induced oral mucositis. Evid Based Complement Alternat Med (2013) 0.78
Preclinical evaluation on the tumor suppression efficiency and combination drug effects of fermented wheat germ extract in human ovarian carcinoma cells. Evid Based Complement Alternat Med (2015) 0.78
Chinese Herbal Medicines as an Adjunctive Therapy for Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med (2015) 0.78
Acupuncture and herbal medicine for cancer patients. Evid Based Complement Alternat Med (2013) 0.77
Chinese Herbal Medicine as an Adjunctive Therapy for Breast Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med (2016) 0.77
Fangchinoline inhibits the proliferation of SPC-A-1 lung cancer cells by blocking cell cycle progression. Exp Ther Med (2015) 0.76
Systematic review and meta-analysis in chinese medicine. Evid Based Complement Alternat Med (2014) 0.75
Effectiveness of Chinese herbal medicine for cancer palliative care: overview of systematic reviews with meta-analyses. Sci Rep (2015) 0.75
The Effectiveness of Traditional Chinese Medicine in Treating Patients with Leukemia. Evid Based Complement Alternat Med (2016) 0.75
The Fruit Hull of Gleditsia sinensis Enhances the Anti-Tumor Effect of cis-Diammine Dichloridoplatinum II (Cisplatin). Evid Based Complement Alternat Med (2016) 0.75
Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients. Sci Rep (2017) 0.75
Crocin inhibits cell proliferation and enhances cisplatin and pemetrexed chemosensitivity in lung cancer cells. Transl Lung Cancer Res (2015) 0.75
Fuling Granule, a Traditional Chinese Medicine Compound, Suppresses Cell Proliferation and TGFβ-Induced EMT in Ovarian Cancer. PLoS One (2016) 0.75
Metabolic study of Angelica dahurica extracts using a reusable liver microsomal nanobioreactor by liquid chromatography-mass spectrometry. Biomed Chromatogr (2015) 0.75
Efficacy of traditional Chinese medicine in treating cancer. Biomed Rep (2015) 0.75
Chinese Herbal Medicine as Adjunctive Therapy to Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med (2016) 0.75
Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients. J Cancer Res Clin Oncol (2017) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol (2003) 6.66
Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer (1980) 4.31
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. J Clin Oncol (2011) 3.21
Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol (2005) 2.87
Clinical predictors of survival in advanced cancer. J Support Oncol (2005) 2.53
Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer. J Clin Oncol (2009) 2.50
Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol (2006) 2.42
Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med (2008) 2.08
Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis. J Thorac Oncol (2007) 1.86
Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer (2005) 1.76
In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. J Ethnopharmacol (2007) 1.28
Anticancer activities of Oldenlandia diffusa. J Herb Pharmacother (2004) 1.16
In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett (2007) 1.16
Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer (2011) 1.16
Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review. Lung Cancer (2009) 1.11
Guidelines for randomised controlled trials investigating Chinese herbal medicine. J Ethnopharmacol (2011) 1.09
Developments in the treatment of non-small cell lung cancer. Anticancer Res (2007) 1.01
Astragalus membranaceus ameliorates reproductive toxicity induced by cyclophosphamide in male mice. Phytother Res (2012) 1.00
Effects of combined Chinese drugs and chemotherapy in treating advanced non-small cell lung cancer. Chin J Integr Med (2010) 0.95
The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis. Complement Ther Med (2012) 0.94
[Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial]. Zhong Xi Yi Jie He Xue Bao (2008) 0.93
Clinical efficacy of traditional Chinese medicine as a concomitant therapy for nasopharyngeal carcinoma: a systematic review and meta-analysis. Cancer Invest (2009) 0.93
Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway. Cancer Biol Ther (2007) 0.92
Effects of radix adenophorae and cyclosporine A on an OVA-induced murine model of asthma by suppressing to T cells activity, eosinophilia, and bronchial hyperresponsiveness. Mediators Inflamm (2008) 0.91
Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis. Expert Opin Investig Drugs (2009) 0.91
[Clinical study on treatment of advanced non-small-cell lung cancer with Chinese herbal medicine in different stages combined with chemotherapy]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2007) 0.85
Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer. Int J Clin Oncol (2005) 0.83
Haishengsu as an adjunct therapy to conventional chemotherapy in patients with non-small cell lung cancer: a pilot randomized and placebo-controlled clinical trial. Complement Ther Med (2008) 0.83
[A study on treatment of lung cancer by combined therapy of traditional Chinese medicine and chemotherapy]. Zhongguo Zhong Xi Yi Jie He Za Zhi (1996) 0.81
Protective effect of recombinant human erythropoeitin against cisplatin cytotoxicity and genotoxicity in cultured Vero cells. Exp Toxicol Pathol (2011) 0.80
Treatment with Astragali radix and Angelicae radix enhances erythropoietin gene expression in the cyclophosphamide-induced anemic rat. J Med Food (2009) 0.80
[Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial]. Zhong Xi Yi Jie He Xue Bao (2011) 0.80
A fructan, from Radix ophiopogonis, stimulates the proliferation of cultured lymphocytes: structural and functional analyses. J Nat Prod (2006) 0.80
[The randomized, multicenter, controlled clinic trail for treating advanced non-small cell lung cancer with combined traditional chinese medicine and vinorelbine (Navelbine, NVB) plus cisplatin (DDP) chemotherapy.]. Zhongguo Fei Ai Za Zhi (2008) 0.78
[Assessment of therapeutic efficacy on treating advanced non-small cell lung cancer in the aged by Chinese medicine adopting the international questionnaire of quality of life]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2011) 0.78
Complementary and alternative medicine use in the thyroid patients of a head and neck practice. Otolaryngol Head Neck Surg (2011) 0.77
[Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage IIIB/IV non-small-cell lung cancer: a randomized controlled trial]. Zhong Xi Yi Jie He Xue Bao (2012) 0.77
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol (2012) 2.91
Treatment of menopausal symptoms with Er-xian decoction: a systematic review. Am J Chin Med (2008) 1.53
Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem (2010) 1.42
Review of research on Dendrobium, a prized folk medicine. Appl Microbiol Biotechnol (2012) 1.31
Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia. Clin Chem (2004) 1.18
Use of 3-acetoxymethoxycarbonyl-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl as an EPR oximetry probe: potential for in vivo measurement of tissue oxygenation in mouse brain. Magn Reson Med (2006) 1.18
TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness. Mol Cancer (2014) 1.15
Bear bile: dilemma of traditional medicinal use and animal protection. J Ethnobiol Ethnomed (2009) 1.12
Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation. Liver Int (2007) 1.11
A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma. Int J Cancer (2013) 1.10
Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem (2011) 1.10
Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med (2009) 1.09
Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced acute liver hepatotoxicity in rats. J Ethnopharmacol (2009) 1.04
Personalized targeted therapy for lung cancer. Int J Mol Sci (2012) 1.02
Herba Epimedii: anti-oxidative properties and its medical implications. Molecules (2010) 1.02
Effectiveness and safety of herbal medicines in the treatment of irritable bowel syndrome: a systematic review. World J Gastroenterol (2008) 1.02
Hepatoprotective effects of berberine on carbon tetrachloride-induced acute hepatotoxicity in rats. Chin Med (2010) 0.98
Clinical role of circulating Epstein-Barr virus DNA as a tumor marker in lymphoepithelioma-like carcinoma of the lung. Ann N Y Acad Sci (2004) 0.98
Providing self-healing ability for wireless sensor node by using reconfigurable hardware. Sensors (Basel) (2012) 0.98
An epidemiological study of concomitant use of Chinese medicine and antipsychotics in schizophrenic patients: implication for herb-drug interaction. PLoS One (2011) 0.97
miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents. Curr Cancer Drug Targets (2013) 0.96
Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models? J Ethnopharmacol (2011) 0.95
Chinese medicines as a resource for liver fibrosis treatment. Chin Med (2009) 0.94
Great potential of miRNAs as predictive and prognostic markers for cancer. Expert Rev Mol Diagn (2012) 0.94
F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration. Integr Cancer Ther (2010) 0.94
Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer. Curr Top Med Chem (2012) 0.94
The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis. Complement Ther Med (2012) 0.94
Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong. Cancer Invest (2008) 0.94
Role of miRNAs in lung cancer. Expert Rev Mol Diagn (2009) 0.93
Intestinal absorption and bioavailability of traditional Chinese medicines: a review of recent experimental progress and implication for quality control. J Pharm Pharmacol (2012) 0.93
Senkyunolides reduce hydrogen peroxide-induced oxidative damage in human liver HepG2 cells via induction of heme oxygenase-1. Chem Biol Interact (2009) 0.92
Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury. J Neurochem (2006) 0.91
Over-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of β-catenin. Int J Mol Sci (2013) 0.91
Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP⁺, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells. Neurosci Lett (2012) 0.90
Quality assessment of Cortex Phellodendri by high-performance liquid chromatography coupled with electrospray ionization mass spectrometry. Biomed Chromatogr (2010) 0.88
Recent progress in genetic variants associated with cancer and their implications in diagnostics development. Expert Rev Mol Diagn (2010) 0.88
The implications of cancer stem cells for cancer therapy. Int J Mol Sci (2012) 0.87
Proteomics and translational medicine: molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome. Expert Rev Proteomics (2011) 0.87
Exploiting the therapeutic potential of microRNAs in human cancer. Expert Opin Ther Targets (2012) 0.87
Biomarker discovery of nasopharyngeal carcinoma by proteomics. Expert Rev Proteomics (2014) 0.87
A randomized, double-blind, controlled trial of a Chinese herbal formula (Er-Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause (2013) 0.86
Pharmacological induction of leukotriene B4-12-hydroxydehydrogenase suppresses the oncogenic transformation of human hepatoma HepG2 cells. Int J Oncol (2011) 0.85
Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med (2013) 0.85
Four-stage dissolved oxygen strategy based on multi-scale analysis for improving spinosad yield by Saccharopolyspora spinosa ATCC49460. Microb Biotechnol (2015) 0.85
Caveolin-1 plays a crucial role in inhibiting neuronal differentiation of neural stem/progenitor cells via VEGF signaling-dependent pathway. PLoS One (2011) 0.85
Chrysotoxine, a novel bibenzyl compound, inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-κB modulation. Neurochem Int (2010) 0.85
Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials. Chin Med (2012) 0.85
mTOR activation in immature cells of primary nasopharyngeal carcinoma and anti-tumor effect of rapamycin in vitro and in vivo. Cancer Lett (2013) 0.84
Dietary supplement with a combination of Rhodiola crenulata and Ginkgo biloba enhances the endurance performance in healthy volunteers. Chin J Integr Med (2009) 0.84
Molecular diagnostics for monitoring and predicting therapeutic effect in cancer. Expert Rev Mol Diagn (2011) 0.84
TCM Zheng Classification and Clinical Trials. Evid Based Complement Alternat Med (2013) 0.84
Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers. Expert Rev Proteomics (2014) 0.84
Cell budding from normal appearing epithelia: a predictor of colorectal cancer metastasis? Int J Biol Sci (2013) 0.83
MicroRNAs: mechanisms, functions and progress. Genomics Proteomics Bioinformatics (2012) 0.83
Deep proteome profiling of sera from never-smoked lung cancer patients. Biomed Pharmacother (2007) 0.83
A comparative study on the hepatoprotective action of bear bile and Coptidis Rhizoma aqueous extract on experimental liver fibrosis in rats. BMC Complement Altern Med (2012) 0.83
MicroRNAs as therapeutic targets for lung cancer. Expert Opin Ther Targets (2010) 0.83
Anti-angiogenic activity of Erxian Decoction, a traditional Chinese herbal formula, in zebrafish. Biol Pharm Bull (2012) 0.83
Dendrobium officinale polysaccharides ameliorate the abnormality of aquaporin 5, pro-inflammatory cytokines and inhibit apoptosis in the experimental Sjögren's syndrome mice. Int Immunopharmacol (2011) 0.83
RGD peptides protects against acute lung injury in septic mice through Wisp1-integrin β6 pathway inhibition. Shock (2015) 0.83
RGS19 inhibits Ras signaling through Nm23H1/2-mediated phosphorylation of the kinase suppressor of Ras. Cell Signal (2013) 0.82
Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer. Expert Rev Mol Diagn (2011) 0.82
Towards developing biomarkers for glioblastoma multiforme: a proteomics view. Expert Rev Proteomics (2014) 0.82
Anti-angiogenic activity of Herba Epimedii on zebrafish embryos in vivo and HUVECs in vitro. Phytother Res (2012) 0.81
A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia. J Clin Psychopharmacol (2008) 0.81
Caveolin-1 inhibits oligodendroglial differentiation of neural stem/progenitor cells through modulating β-catenin expression. Neurochem Int (2011) 0.81
Identification of the major chemical constituents and their metabolites in rat plasma and various organs after oral administration of effective Erxian Decoction (EXD) fraction by liquid chromatography-mass spectrometry. Biomed Chromatogr (2010) 0.81
Chinese herbal medicine for infertility with anovulation: a systematic review. J Altern Complement Med (2012) 0.81
Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells. Phytother Res (2010) 0.81
Stratification of clear cell renal cell carcinoma by signaling pathway analysis. Expert Rev Proteomics (2014) 0.81
Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease. Clin Cancer Res (2002) 0.81
Characterization of steroidal saponins in crude extract from Dioscorea nipponica Makino by liquid chromatography tandem multi-stage mass spectrometry. Anal Chim Acta (2007) 0.80
Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents. Curr Cancer Drug Targets (2013) 0.80
A DNA microarray for differentiation of (Fengdou Shihu) by its 5 S ribosomal DNA intergenic spacer region. Biotechnol Appl Biochem (2008) 0.80
Comparative analysis of caffeoylquinic acids and lignans in roots and seeds among various burdock (Arctium lappa) genotypes with high antioxidant activity. J Agric Food Chem (2012) 0.80
Phosphoproteomics and lung cancer research. Int J Mol Sci (2012) 0.79
Ketamine does not increase intracranial pressure compared with opioids: meta-analysis of randomized controlled trials. J Anesth (2014) 0.79
Targeting the signaling pathways in cancer therapy. Expert Opin Ther Targets (2012) 0.79
Ginkgo biloba extract (EGb761) inhibits mitochondria-dependent caspase pathway and prevents apoptosis in hypoxia-reoxygenated cardiomyocytes. Chin Med (2011) 0.78
Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era. Expert Rev Anti Infect Ther (2014) 0.78
Effects of Erxian decoction, a Chinese medicinal formulation, on serum lipid profile in a rat model of menopause. Chin Med (2011) 0.78
Differential effects of classical and atypical antipsychotic drugs on rotenone-induced neurotoxicity in PC12 cells. Eur Neuropsychopharmacol (2007) 0.78
[Jatropha seed oils extracted by different methods and their effect on killing cercaria of Schistosoma japonicum]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi (2014) 0.78
Chemical and biological analysis of active free and conjugated bile acids in animal bile using HPLC-ELSD and MTT methods. Exp Ther Med (2010) 0.78
Application of SCAR (sequence characterized amplified region) analysis to authenticate Lycium barbarum (wolfberry) and its adulterants. Biotechnol Appl Biochem (2008) 0.78
Regulator of G protein signaling 19 suppresses Ras-induced neoplastic transformation and tumorigenesis. Cancer Lett (2013) 0.78
Tian Xian Liquid (TXL) induces apoptosis in HT-29 colon cancer cell in vitro and inhibits tumor growth in vivo. Chin Med (2010) 0.77
Synthesis of Novel Flower-Like Zn(OH)F via a Microwave-Assisted Ionic Liquid Route and Transformation into Nanoporous ZnO by Heat Treatment. Nanoscale Res Lett (2009) 0.77
Natural products for liver diseases: basic, clinical, and translational research. Evid Based Complement Alternat Med (2012) 0.77
MicroRNAs Involved in Anti-Tumour Immunity. Int J Mol Sci (2013) 0.77
The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study. J Affect Disord (2008) 0.77
An in vitro and in vivo investigation of the antimetastatic effects of a Chinese medicinal decoction, erxian decoction, on human ovarian cancer models. Integr Cancer Ther (2012) 0.76
Targeting signaling pathways in lung cancer therapy. Expert Opin Ther Targets (2012) 0.76
Tube-like structures with co-expression of D2-40 and CD34: newly formed vasculatures? Int J Biol Sci (2012) 0.76
Caveolin-1 promote astroglial differentiation of neural stem/progenitor cells through modulating Notch1/NICD and Hes1 expressions. Biochem Biophys Res Commun (2011) 0.76
Trastuzumab emtansine for advanced HER2-positive breast cancer and beyond: genome landscape-based targets. Expert Rev Anticancer Ther (2013) 0.76
Huperzine A as add-on therapy in patients with treatment-resistant schizophrenia: an open-labeled trial. Schizophr Res (2007) 0.76
Regulatory functions of Nm23-H2 in tumorigenesis: insights from biochemical to clinical perspectives. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.75
Putative biomarkers and therapeutic targets associated with radiation resistance. Expert Rev Proteomics (2014) 0.75